SEC Form 4 · accession 0001104659-19-003198
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Walter Peltz
Officer — Chief Executive Officer · Director
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 5:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 22, 2019 | A | 4,620 | $0.00 | A | 22,158 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $33.02 | Jan 22, 2019 | A | 265,000 | A | — | Jan 21, 2029 | Common Stock | 265,000 | 265,000 | D |
| Stock Option (Right to Buy)F3 | $33.02 | Jan 22, 2019 | A | 55,000 | A | — | Jan 21, 2029 | Common Stock | 55,000 | 55,000 | D |
| Stock Option (Right to Buy)F2 | $33.02 | Jan 22, 2019 | A | 26,950 | A | — | Jan 21, 2029 | Common Stock | 26,950 | 26,950 | I |
Explanation of responses
- F1Restricted stock award granted on January 22, 2019 that vests in four equal installments over four years, commencing on January 22, 2020.
- F2This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
- F3This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.